Cargando…
A Novel Case of Cytomegalovirus Pneumonia in an Acquired Thrombotic Thrombocytopenic Purpura Patient Treated With Rituximab
Thrombotic thrombocytopenic purpura (TTP) is thrombotic microangiopathy that is universally fatal if not promptly recognized and treated. Standard treatment includes plasma exchange (PLEX) therapy and immunosuppression. We present a case of an 80 years old African American male with a past medical h...
Autores principales: | Kandah, Emad, Konda, Raghunandan, Kalantary, Atefeh, Madadha, Adan, Kunadi, Arvind |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082315/ https://www.ncbi.nlm.nih.gov/pubmed/33936893 http://dx.doi.org/10.7759/cureus.14182 |
Ejemplares similares
-
Dysphagia as the Presenting Symptom of Laryngeal Tuberculosis
por: Kandah, Emad, et al.
Publicado: (2021) -
Immune Thrombocytopenic Purpura (ITP) Following Natural COVID-19 Infection
por: Santhosh, Sisira, et al.
Publicado: (2022) -
Rituximab as first-line treatment for acquired thrombotic thrombocytopenic purpura
por: Chen, Haifei, et al.
Publicado: (2017) -
Clinical Efficacy and Safety Profile of Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura
por: Maqsood, Muhammad Haisum, et al.
Publicado: (2019) -
Valacyclovir-Induced Thrombotic Thrombocytopenic Purpura
por: Bukhari, Sumera, et al.
Publicado: (2020)